How Pharma Brands Monitor AI: A Step-by-Step Strategy for LLM Search Visibility, Drug Safety, and Share of Voice
In 2023, a patient asked ChatGPT whether she could take Eliquis with ibuprofen. ChatGPT told her the combination was generally […]
In 2023, a patient asked ChatGPT whether she could take Eliquis with ibuprofen. ChatGPT told her the combination was generally […]
The medical science liaison had just finished a physician meeting when the rep on the account pulled out his phone.
A hospitalist in Cleveland needs to know the renal dosing adjustment for a patient on apixaban with a creatinine clearance
Before a drug problem reaches the FDA, it travels through the internet. A cluster of patient forum posts. A Reddit
A patient types a question into ChatGPT: “Can I take metformin and ibuprofen together?” The AI answers in seconds —
Somewhere right now, a patient is asking ChatGPT whether their cancer drug will extend their life. A caregiver is asking
A parent in Texas asks ChatGPT how much ibuprofen to give her 18-month-old. ChatGPT returns a dose calculated for a
The shift happened without a product launch, without a press release, and without a single pharmaceutical company authorizing it. Sometime
Walk into any pharmaceutical compliance team’s weekly meeting and you’ll find the same agenda items from the past decade: OPDP
How drug brands fought off-label prescribing to survive: real FDA cases, litigation wins, and what AI monitoring means for pharmacovigilance
Why migraine drugs became weight-loss forums, cholesterol pills turned into food-interaction experiments, and cancer therapies spawned Reddit-scale crowdsourced medicine. There’s
AI Pharmacovigilance: How Drug Companies Track Safety Signals Before Regulators Do The FDA receives roughly 2 million adverse event reports
Sign in or create a free account to read this DrugChatter article